Open Orphan PLC (AIM:ORPH, OTC:OPORF) said its clinical laboratories in Queen Mary's Bioenterprise Centre and Plumbers Row have been awarded accreditation by the College of American Pathologists (CAP).
The accreditation was sought from the world's largest pathologist body as part of its “ongoing commitment to maintaining best in class quality systems”, the company said, ensuring for US clients the accuracy of test results and conforming to the requirements from the US Food and Drug Administration (FDA).
CAP accreditation “supports laboratories performing testing on specimens from human, using methodologies and clinical application within the expertise of the program”, and expands on the Good Clinical Practice for Laboratories (GCLP) accreditation from the UK regulator.
Brandon Londt, hVIVO’s development operations director for the company's hLab developments, said: "We are proud to have received the CAP accreditation, which is recognition of the quality of our laboratory and further demonstrates our commitment to maintaining the highest standards of excellence and ensuring that our work practices meet the rigorous CAP assessment standards. This accreditation will provide current and future clients a further degree of confidence in the quality of work performed in our laboratory and assurances of the results we produce."